Tadalafil Tablet
Product Images NDC 70954-433

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 70954-433). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

New1 (Fig 2)

FDA Label Image

Three (Fig 3new)

FDA Label Image

Seven (Fig 7new)

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
This is a table of blood pressure readings, comparing the difference between Tadalafil and Placebo for both standing and supine positions. The table also shows the time in hours.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
This is a graph showing the plasma concentration of Tadalafil, a medication used to treat erectile dysfunction. The graph displays the concentration of Tadalafil in ug/L over time in hours, with a single 20-mg dose, a single 5-mg dose, and the once-daily 5-mg Tadalafil regimen following five consecutive days of administration.*
FDA Label Image

Figure-5 (Figure 5)

FDA Label Image

Figure-6 (Figure 6)

FDA Label Image

Figure-8 (Figure 8)

Figure-8 (Figure 8)
The text provides information on the effectiveness of CIAUS 5mg as compared to a placebo in reducing the IPSS Total Score over a certain treatment duration of weeks. The data is statistically significant with a p-value less than 0.01.*
FDA Label Image

Container-2 (Label 10 mg)

Container-2 (Label 10 mg)
This is a medicine package containing 30 tablets of Tadalafil, with each tablet containing 10mg of Tadalafil, USP. The package warns not to split the tablets and to take the full dose. It also instructs to refer to the accompanying literature for dosage. The medicine should be stored in a dry place at a temperature between 20°C to 25°C. The manufacturer is Novitium Pharma LLC, located in New Jersey, and the package has a warning to keep out of reach of children.*
FDA Label Image

Container-3 (Label 20 mg)

Container-3 (Label 20 mg)
This is a medication with National Drug Code (NDC) 70954-435-10 consisting of 30 tablets of Tadalafil with each tablet containing 20 mg of Tadalafil, USP. It is used as per the accompanying literature and should not be split. It should be stored at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F) and dispensed in a tight container. The medication is manufactured by Novitium Pharma LLC, located in New Jersey, and this information was issued in April 2022.*
FDA Label Image

Container-1 (Label 5 mg)

Container-1 (Label 5 mg)
This is a description of a medication labeled as Tadalafil. It is available in a bottle of 30 tablets, and each tablet contains 5 mg of Tadalafil, USP. The recommended dosage should be taken as per the accompanying literature, and tablets should not be split. The medicine should be stored at 20-25°C and kept out of children's reach. Dispensing should be done in a tight container. It is manufactured by Novitium Pharma LLC and was issued in April 2022.*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.